The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NVST | +8.13% | -27.14% | -6.14% | -28% |
| S&P | +15.06% | +95.03% | +14.29% | +124% |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $682.10M | 7.7% |
| Gross Profit | $370.20M | 12.2% |
| Gross Margin | 54.27% | 2.2% |
| Market Cap | $3.31B | 15.9% |
| Market Cap / Employee | $0.27M | 0.0% |
| Employees | 12.3K | -3.9% |
| Net Income | $26.40M | 102.3% |
| EBITDA | $80.60M | 100.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.11B | 7.2% |
| Accounts Receivable | $422.80M | 11.1% |
| Inventory | 281.9 | 6.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.56B | 4.5% |
| Short Term Debt | $36.10M | -76.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 0.97% | 23.0% |
| Return On Invested Capital | -3.38% | -6.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $76.40M | -11.5% |
| Operating Free Cash Flow | $88.70M | -4.7% |
| Metric | Q2 2025 | YoY Change | |||
|---|---|---|---|---|---|
| Price to Earnings | 62.76 | - | |||
| Price to Book | 1.14 | 1.08 | 1.01 | 1.10 | 59.86% |
| Price to Sales | 1.36 | 1.33 | 1.18 | 1.31 | 15.89% |
| Price to Tangible Book Value | -666.03 | 77.88 | 129.22 | 40.62 | -154.28% |
| Price to Free Cash Flow TTM | 12.53 | 11.07 | 11.00 | 12.96 | 29.72% |
| Enterprise Value to EBITDA | 77.37 | 43.96 | 44.42 | 47.49 | -44.82% |
| Free Cash Flow Yield | 8.0% | 9.0% | 9.1% | 7.7% | -22.91% |
| Return on Equity | -36.3% | -31.5% | -31.3% | 1.8% | -104.84% |
| Total Debt | $1.58B | $1.55B | $1.56B | $1.60B | -2.83% |
NVST earnings call for the period ending September 30, 2021.
NVST earnings call for the period ending June 30, 2021.
NVST earnings call for the period ending March 24, 2021.
NVST earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
